AIGH Capital Management’s Abeona Therapeutics ABEO Stock Holding History

AIGH Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.2M	Sell	2,900,000 -87,000	-3%	-$540K	1.54%	20
2026 Q2	$18.5M	Sell	2,987,000 -113,000	-4%	-$620K	1.16%	18
2026 Q1	$13.9M	Buy	3,100,000 +1,100,000	+55%	+$5.5M	1.89%	16
2025 Q4	$10.5M	Buy	+2,000,000	New	+$10.1M	2.55%	14
2024 Q1	–	Sell	-787,769	Closed	-$3.95M	–	44
2023 Q4	$3.95M	Sell	787,769 -347,483	-31%	-$1.53M	1.56%	25
2023 Q3	$4.78M	Buy	1,135,252 +496,278	+78%	+$1.88M	2.26%	17
2023 Q2	$2.58M	Sell	638,974 -13,200	-2%	-$46.2K	1.05%	24
2023 Q1	$1.84M	Hold	652,174	–	–	0.68%	34
2022 Q4	$2.01M	Buy	652,174 +511,530	+364%	+$1.91M	0.66%	32
2022 Q3	$428K	Buy	+140,644	New	+$580K	0.13%	42
2022 Q2	–	Sell	-201,004	Closed	-$1.58M	–	48
2022 Q1	$1.58M	Buy	201,004 +155,513	+342%	+$1.07M	0.39%	32
2021 Q4	$383K	Buy	+45,491	New	+$836K	0.12%	47

Other funds holding ABEO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

AIGH Capital Management's ABEO Position: Q3 2026 in Review

AIGH Capital Management reduced its Abeona Therapeutics (ABEO) stake by 2.9% in Q3 2026, selling an estimated $540K and leaving 2,900,000 shares worth $15.2M. The position accounts for 1.54% of the portfolio, ranked #20.

AIGH Capital Management first reported a position in ABEO in Q4 2021 and has held it in 12 quarters since. The position peaked at $18.5M in Q2 2026. 37 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

AIGH Capital Management held 2,900,000 shares of Abeona Therapeutics worth $15.2M as of Q3 2026.
AIGH Capital Management sold 87,000 Abeona Therapeutics shares in Q3 2026, an estimated $540K.
Abeona Therapeutics made up 1.54% of AIGH Capital Management's portfolio in Q3 2026, its #20 holding.
AIGH Capital Management first reported a position in Abeona Therapeutics in Q4 2021 and has held it in 12 quarters since.
AIGH Capital Management's Abeona Therapeutics position peaked at $18.5M in Q2 2026.
37 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on AIGH Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.